The Lions Vision Research and Rehabilitation Center at the Johns Hopkins University School of Medicine, Baltimore, Maryland.
Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
JAMA Ophthalmol. 2018 Jan 1;136(1):12-19. doi: 10.1001/jamaophthalmol.2017.4655.
Updated estimates of the prevalence and incidence rates of low vision and blindness are needed to inform policy makers and develop plans to meet the future demands for low vision rehabilitation services.
To provide updated estimates of the incidence and prevalence of low vision and blindness in the United States.
DESIGN, SETTING, AND PARTICIPANTS: Visual acuity measurements as a function of age from the 2007-2008 National Health and Nutrition Examination Survey, with representation of racial and ethnic groups, were used to estimate the prevalence and incidence of visual impairments. Data from 6016 survey participants, ranging in age from younger than 18 years to older than 45 years, were obtained to estimate prevalence rates for different age groups. Incidence and prevalence rates of low vision (best-corrected visual acuity [BCVA] in the better-seeing eye of <20/40 and <20/60) and blindness (BCVA of ≤20/200) in older adults were estimated from exponential models, fit to prevalence rates as a function of age (specified in 5-year age bins). The prevalence and annual incidence of low vision and blindness in the United States were estimated, using the 2010 US census data by age, from the rate models applied to the census projections for 2017, 2030, and 2050. Data were collected from November 1, 2007, to October 31, 2008. Data analysis took place from March 31, 2016, to March 19, 2017.
Prevalence and incidence rates of low vision and blindness in the United States.
Of the 6016 people in the study, 1714 (28.4%) were younger than 18 years of age, 2358 (39.1%) were 18 to 44 years of age, and 1944 (32.3%) were 45 years of age or older. There were 2888 male (48%) and 3128 female (52%) participants. The prevalence of low vision and blindness for older adults (≥45 years) in the United States in 2017 is estimated to be 3 894 406 persons (95% CI, 3 034 442-4 862 549 persons) with a BCVA less than 20/40, 1 483 703 persons (95% CI, 968 656-2 370 513 persons) with a BCVA less than 20/60, and 1 082 790 persons (95% CI, 637 771-1 741 864 persons) with a BCVA of 20/200 or less. The estimated 2017 annual incidence (projected from 2010 census data) of low vision and blindness among older adults (≥45 years) in the United States is 481 970 persons (95% CI, 375 541-601 787 persons) with a BCVA less than 20/40, 183 618 persons (95% CI, 119 878-293 367 persons) with a BCVA less than 20/60, and 134 002 persons (95% CI, 83 383-215 567 persons) with a BCVA of 20/200 or less. The total annual incidence for each BCVA criterion is 12.4% of the total prevalence.
Low vision and blindness affect a substantial portion of the older population in the United States. Estimates of the prevalence and annual incidence of visual impairment assist policy planners in allocating and developing resources for this life-changing loss of function.
更新美国低视力和失明的患病率和发病率估计值对于为决策者提供信息并制定计划以满足未来对低视力康复服务的需求非常重要。
提供美国低视力和失明的发病率和患病率的最新估计值。
设计、设置和参与者:使用 2007-2008 年全国健康和营养检查调查的视力测量值(按年龄分组),具有种族和族裔群体的代表性,用于估计视力障碍的患病率和发病率。从年龄在 18 岁以下到 45 岁以上的 6016 名调查参与者中获得数据,以估计不同年龄组的患病率。使用指数模型从患病率(以 5 岁年龄组指定)作为年龄的函数来估计老年人中低视力(最佳矫正视力[BCVA]在较好眼视力低于 20/40 和 20/60)和失明(BCVA 小于等于 20/200)的发病率和患病率。使用 2010 年美国人口普查数据按年龄估算美国低视力和失明的患病率和年发病率,从适用于 2017 年、2030 年和 2050 年人口普查预测的率模型中应用。数据收集于 2007 年 11 月 1 日至 2008 年 10 月 31 日。数据分析于 2016 年 3 月 31 日至 2017 年 3 月 19 日进行。
美国低视力和失明的患病率和发病率。
在这项研究的 6016 人中,有 1714 人(28.4%)年龄小于 18 岁,2358 人(39.1%)年龄在 18 至 44 岁之间,1944 人(32.3%)年龄在 45 岁或以上。男性参与者 2888 人(48%),女性参与者 3128 人(52%)。美国年龄在 45 岁或以上的老年人(≥45 岁)中,2017 年低视力和失明的患病率估计为 3894406 人(95%CI,3034442-4862549 人),视力低于 20/40,1483703 人(95%CI,968656-2370513 人),视力低于 20/60,1082790 人(95%CI,637771-1741864 人),视力低于 20/200。美国年龄在 45 岁或以上的老年人(≥45 岁)中,2017 年低视力和失明的估计年发病率(从 2010 年人口普查数据预测)为 481970 人(95%CI,375541-601787 人),视力低于 20/40,183618 人(95%CI,119878-293367 人),视力低于 20/60,134002 人(95%CI,83383-215567 人),视力低于 20/200。每个 BCVA 标准的总发病率占总患病率的 12.4%。
低视力和失明影响美国老年人的很大一部分。视力障碍患病率和年发病率的估计值有助于政策规划者为这一改变生活的功能丧失分配和制定资源。